Cargando…

Expression of OCT4 isoforms is reduced in primary colorectal cancer

INTRODUCTION: Colorectal cancer (CRC) is one of the most common types of cancer worldwide. The carcinogenesis of CRC is indeed complex, and there are many different mechanisms and pathways that contribute to the development of malignancy and the progression from primary to metastatic tumors. The OCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Turyova, Eva, Mikolajcik, Peter, Grendar, Marian, Kudelova, Eva, Holubekova, Veronika, Kalman, Michal, Marcinek, Juraj, Hrnciar, Matej, Kovac, Michal, Miklusica, Juraj, Laca, Ludovit, Lasabova, Zora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319064/
https://www.ncbi.nlm.nih.gov/pubmed/37409260
http://dx.doi.org/10.3389/fonc.2023.1166835
_version_ 1785068165598806016
author Turyova, Eva
Mikolajcik, Peter
Grendar, Marian
Kudelova, Eva
Holubekova, Veronika
Kalman, Michal
Marcinek, Juraj
Hrnciar, Matej
Kovac, Michal
Miklusica, Juraj
Laca, Ludovit
Lasabova, Zora
author_facet Turyova, Eva
Mikolajcik, Peter
Grendar, Marian
Kudelova, Eva
Holubekova, Veronika
Kalman, Michal
Marcinek, Juraj
Hrnciar, Matej
Kovac, Michal
Miklusica, Juraj
Laca, Ludovit
Lasabova, Zora
author_sort Turyova, Eva
collection PubMed
description INTRODUCTION: Colorectal cancer (CRC) is one of the most common types of cancer worldwide. The carcinogenesis of CRC is indeed complex, and there are many different mechanisms and pathways that contribute to the development of malignancy and the progression from primary to metastatic tumors. The OCT4A, encoded by the POU5F1 gene, is a transcription factor responsible for the phenotype of stem cells, maintaining pluripotency and regulation of differentiation. The POU5F1 gene is made up of five exons that can create numerous isoforms through alternative promoter or alternative splicing. In addition to OCT4A, other isoforms called OCT4B are also translated into protein; however, their role in cells has been unclear. The aim of our work was to investigate the expression patterns of OCT4 isoforms in primary and metastatic CRC, providing us with useful information about their role in the development and progression of CRC. METHODS: Surgical specimens from a total of 78 patients were collected and isolated from primary tumors (n = 47) and metastases (n = 31). The relative gene expression of OCT4 isoforms was investigated using the RT-qPCR method together with the TaqMan probes for particular OCT4 isoforms. RESULTS: Our results suggest significantly downregulated expression of the OCT4A and OCT4Bs isoforms in both primary (p = 0.0002 and p < 0.0001, respectively) and metastatic tumors (p = 0.0006 and p = 0.00051, respectively) when compared with the control samples. We also observed a correlation between reduced expression of all OCT4 isoforms and both primary and left-sided tumors (p = 0.001 and p = 0.030, respectively). On the other hand, the expression of all OCT4 isoforms was significantly upregulated in metastases compared with primary tumors (p < 0.0001). DISCUSSION: Unlike previous reports, we found out that the expression of OCT4A, OCT4Bs, and all OCT4 isoforms was significantly reduced in primary tumors and metastases compared with control samples. On the other hand, we supposed that the expression rate of all OCT4 isoforms may be related to the cancer type and side, as well as to liver metastases. However, further studies are required to investigate the detailed expression patterns and significance of individual OCT4 isoforms in carcinogenesis.
format Online
Article
Text
id pubmed-10319064
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103190642023-07-05 Expression of OCT4 isoforms is reduced in primary colorectal cancer Turyova, Eva Mikolajcik, Peter Grendar, Marian Kudelova, Eva Holubekova, Veronika Kalman, Michal Marcinek, Juraj Hrnciar, Matej Kovac, Michal Miklusica, Juraj Laca, Ludovit Lasabova, Zora Front Oncol Oncology INTRODUCTION: Colorectal cancer (CRC) is one of the most common types of cancer worldwide. The carcinogenesis of CRC is indeed complex, and there are many different mechanisms and pathways that contribute to the development of malignancy and the progression from primary to metastatic tumors. The OCT4A, encoded by the POU5F1 gene, is a transcription factor responsible for the phenotype of stem cells, maintaining pluripotency and regulation of differentiation. The POU5F1 gene is made up of five exons that can create numerous isoforms through alternative promoter or alternative splicing. In addition to OCT4A, other isoforms called OCT4B are also translated into protein; however, their role in cells has been unclear. The aim of our work was to investigate the expression patterns of OCT4 isoforms in primary and metastatic CRC, providing us with useful information about their role in the development and progression of CRC. METHODS: Surgical specimens from a total of 78 patients were collected and isolated from primary tumors (n = 47) and metastases (n = 31). The relative gene expression of OCT4 isoforms was investigated using the RT-qPCR method together with the TaqMan probes for particular OCT4 isoforms. RESULTS: Our results suggest significantly downregulated expression of the OCT4A and OCT4Bs isoforms in both primary (p = 0.0002 and p < 0.0001, respectively) and metastatic tumors (p = 0.0006 and p = 0.00051, respectively) when compared with the control samples. We also observed a correlation between reduced expression of all OCT4 isoforms and both primary and left-sided tumors (p = 0.001 and p = 0.030, respectively). On the other hand, the expression of all OCT4 isoforms was significantly upregulated in metastases compared with primary tumors (p < 0.0001). DISCUSSION: Unlike previous reports, we found out that the expression of OCT4A, OCT4Bs, and all OCT4 isoforms was significantly reduced in primary tumors and metastases compared with control samples. On the other hand, we supposed that the expression rate of all OCT4 isoforms may be related to the cancer type and side, as well as to liver metastases. However, further studies are required to investigate the detailed expression patterns and significance of individual OCT4 isoforms in carcinogenesis. Frontiers Media S.A. 2023-06-20 /pmc/articles/PMC10319064/ /pubmed/37409260 http://dx.doi.org/10.3389/fonc.2023.1166835 Text en Copyright © 2023 Turyova, Mikolajcik, Grendar, Kudelova, Holubekova, Kalman, Marcinek, Hrnciar, Kovac, Miklusica, Laca and Lasabova https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Turyova, Eva
Mikolajcik, Peter
Grendar, Marian
Kudelova, Eva
Holubekova, Veronika
Kalman, Michal
Marcinek, Juraj
Hrnciar, Matej
Kovac, Michal
Miklusica, Juraj
Laca, Ludovit
Lasabova, Zora
Expression of OCT4 isoforms is reduced in primary colorectal cancer
title Expression of OCT4 isoforms is reduced in primary colorectal cancer
title_full Expression of OCT4 isoforms is reduced in primary colorectal cancer
title_fullStr Expression of OCT4 isoforms is reduced in primary colorectal cancer
title_full_unstemmed Expression of OCT4 isoforms is reduced in primary colorectal cancer
title_short Expression of OCT4 isoforms is reduced in primary colorectal cancer
title_sort expression of oct4 isoforms is reduced in primary colorectal cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319064/
https://www.ncbi.nlm.nih.gov/pubmed/37409260
http://dx.doi.org/10.3389/fonc.2023.1166835
work_keys_str_mv AT turyovaeva expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT mikolajcikpeter expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT grendarmarian expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT kudelovaeva expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT holubekovaveronika expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT kalmanmichal expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT marcinekjuraj expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT hrnciarmatej expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT kovacmichal expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT miklusicajuraj expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT lacaludovit expressionofoct4isoformsisreducedinprimarycolorectalcancer
AT lasabovazora expressionofoct4isoformsisreducedinprimarycolorectalcancer